Covid 19 Vaccine

Government advisory panel NTAGI will meet on Thursday to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses from the current nine to six months. ...

Even vaccinated people with mild breakthrough infections can experience Long COVID - debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to a study of over 13 million people in the US. The ...

Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both - Covishield as the first dose and Covaxin as the second dose - in the ...

Novavax's Covid-19 vaccine named Covovax received emergency use authorization from the Drugs Controller General of India (DCGI) on Tuesday for adolescents aged 12 to 17 years in India. According to Novavax, the vaccine, also known as NVX-CoV2373, is developed ...

The AIIMS will start the booster dose trial of Bharat Biotech's intranasal COVID-19 vaccine from Friday. The booster dose will be given to those who have received both the doses of either Covaxin or Covishield at least five months ago but ...

Noting that the decision on third dose of COVID-19 vaccine for all adults will be taken based on scientific need, the government said on February 10 that emerging knowledge on the subject is under active consideration. Responding to a question ...

Israel is poised to begin administering the fourth dose of the COVID-19 vaccine for medical personnel and people aged 60 and above in a bid to curb the spread of Omicron infections in the country, the Prime Minister's Office said on ...

Apollo Hospitals today inaugurated the vaccination program for children in the age group of 15 to 18 years. This is in line with the Hon'ble Prime Minister's announcement of the expansion of the COVID vaccination program to include children above the ...

India's drug regulator on Friday approved Serum Institute of India's proposal to manufacture a drug substance for the new Covid vaccine against the Omicron variant of coronavirus and carry out its testing and analysis, official sources said. The move assumes ...

There have been extensive deliberations on whether the precautionary (third) dose of Covid vaccine for healthcare and frontline workers and citizens above 60 years with comorbidities should be the same as the first two doses and a decision is expected soon, ...

India-US collaboration in the health sector is in the spotlight as the Central Drug Authority this week approved two more Covid vaccines Corbevax and Covovax and antiviral drug Molnupiravir for use in India. Taranjit Singh Sandhu, India's Ambassador to the ...

Of the vaccines against COVID-19 approved in India, Covovax would be a better booster for those who were administered Covishield jabs than another dose of the same vaccine, according to the data available presently, noted virologist Dr Shahid Jameel said. {image-cover-1640841559.jpeg ...